Skip to main content

Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast.

Publication ,  Journal Article
Moorman, PG; Grubber, JM; Millikan, RC; Newman, B
Published in: Epidemiology
May 2003

BACKGROUND: Experimental studies in animals have suggested that antidepressants may promote the growth of mammary tumors, but epidemiologic data have not shown consistent associations between antidepressant use and breast cancer. METHODS: We analyzed data from a population-based, case-control study conducted in North Carolina from 1996 to 2000 to examine the association between antidepressant use and breast cancer. Logistic regression models were used to estimate odds ratios (ORs) and 95% confidence intervals (CIs) separately for invasive breast cancer and carcinoma in situ. RESULTS: Over 20% of both cases and controls reported having ever used antidepressants. Overall, women with invasive breast cancer did not report antidepressant use more frequently than controls (OR = 1.0; CI = 0.7-1.2). There was a suggestion that use of selective serotonin reuptake inhibitor antidepressants for 36 months or more was more common among the breast cancer cases (OR = 2.7; CI = 0.9-7.9). Carcinoma in situ cases reported antidepressant use less frequently than controls (OR = 0.6; CI = 0.4-0.8). No consistent relation was observed between duration of use and carcinoma in situ. CONCLUSIONS: Antidepressant use in general was not related to an increased risk of breast cancer. There may be increased risk associated with long-term use of SSRIs. Continued monitoring of this relation is warranted, given the high prevalence of use of these drugs in the general population.

Duke Scholars

Published In

Epidemiology

ISSN

1044-3983

Publication Date

May 2003

Volume

14

Issue

3

Start / End Page

307 / 314

Location

United States

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Risk Factors
  • North Carolina
  • Middle Aged
  • Logistic Models
  • Humans
  • Female
  • Epidemiology
  • Case-Control Studies
  • Carcinoma, Ductal, Breast
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Moorman, P. G., Grubber, J. M., Millikan, R. C., & Newman, B. (2003). Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology, 14(3), 307–314.
Moorman, Patricia G., Janet M. Grubber, Robert C. Millikan, and Beth Newman. “Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast.Epidemiology 14, no. 3 (May 2003): 307–14.
Moorman PG, Grubber JM, Millikan RC, Newman B. Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology. 2003 May;14(3):307–14.
Moorman, Patricia G., et al. “Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast.Epidemiology, vol. 14, no. 3, May 2003, pp. 307–14.
Moorman PG, Grubber JM, Millikan RC, Newman B. Antidepressant medications and their association with invasive breast cancer and carcinoma in situ of the breast. Epidemiology. 2003 May;14(3):307–314.

Published In

Epidemiology

ISSN

1044-3983

Publication Date

May 2003

Volume

14

Issue

3

Start / End Page

307 / 314

Location

United States

Related Subject Headings

  • Selective Serotonin Reuptake Inhibitors
  • Risk Factors
  • North Carolina
  • Middle Aged
  • Logistic Models
  • Humans
  • Female
  • Epidemiology
  • Case-Control Studies
  • Carcinoma, Ductal, Breast